Your email has been successfully added to our mailing list.

×
0.00218555349142173 0.00284121953884827 0.00524532837941213 0.00393399628455906 0.00732051141951698 -0.00109277674571079 -0.00185772046770847 -0.00207627581685059
Stock impact report

Baxter Obtains U.S. FDA Emergency Use Authorization for Oxiris Blood Purification Filter for COVID-19 Treatment

Baxter International Inc. (BAX) 
Last baxter international inc. earnings: 4/30 07:15 am Check Earnings Report
US:NYSE Investor Relations: investor.baxter.com
Company Research Source: Business Wire
Only filter set available in the U.S. to reduce pro-inflammatory cytokine levels in the blood, including use in continuous renal replacement therapy (CRRT), for confirmed COVID-19 cases admitted to the ICU with confirmed or imminent respiratory failure who require blood purificationSupport from U.S. Food and Drug Administration (FDA) enabled accelerated authorization processValidated for use with Baxter’s leading blood purification systems, PrisMax and PrismaflexSupplements Baxter’s efforts to increase supply of acute dialysis products that are in high demand DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received emergency use authorization (EUA) from the U.S. FDA for the company’s Oxiris filter set to treat patients who have confirmed COVID-19 and have been admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure in need of blood purification therapy to reduce pro-inflammatory Show less Read more
Impact Snapshot
Event Time:
BAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BAX alerts
Opt-in for
BAX alerts

from News Quantified
Opt-in for
BAX alerts

from News Quantified